Voloridge Investment Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
1,526,892
-96,783
| -6% | -$1.12M | 0.07% | 366 |
|
|
2025
Q1 | $14.2M | Buy |
1,623,675
+37,710
| +2% | +$329K | 0.05% | 453 |
|
|
2024
Q4 | $22.8M | Buy |
1,585,965
+171,161
| +12% | +$2.46M | 0.08% | 315 |
|
|
2024
Q3 | $31.9M | Sell |
1,414,804
-25,238
| -2% | -$570K | 0.12% | 266 |
|
|
2024
Q2 | $28M | Buy |
1,440,042
+538,297
| +60% | +$10.5M | 0.1% | 276 |
|
|
2024
Q1 | $33.8M | Buy |
901,745
+365,024
| +68% | +$13.7M | 0.12% | 229 |
|
|
2023
Q4 | $30M | Sell |
536,721
-19,261
| -3% | -$1.08M | 0.12% | 225 |
|
|
2023
Q3 | $22.9M | Buy |
555,982
+224,942
| +68% | +$9.28M | 0.11% | 250 |
|
|
2023
Q2 | $18.5M | Buy |
331,040
+4,332
| +1% | +$242K | 0.09% | 307 |
|
|
2023
Q1 | $18.2M | Sell |
326,708
-205,494
| -39% | -$11.5M | 0.09% | 311 |
|
|
2022
Q4 | $19.4M | Sell |
532,202
-227,129
| -30% | -$8.28M | 0.11% | 273 |
|
|
2022
Q3 | $21.6M | Sell |
759,331
-23,731
| -3% | -$676K | 0.12% | 244 |
|
|
2022
Q2 | $35.4M | Buy |
783,062
+418,718
| +115% | +$18.9M | 0.18% | 157 |
|
|
2022
Q1 | $27.7M | Buy |
364,344
+351,300
| +2,693% | +$26.7M | 0.16% | 189 |
|
|
2021
Q4 | $1.94M | Buy |
13,044
+4,687
| +56% | +$698K | 0.01% | 1082 |
|
|
2021
Q3 | $1.22M | Sell |
8,357
-19,539
| -70% | -$2.85M | 0.01% | 1219 |
|
|
2021
Q2 | $5.46M | Buy |
27,896
+26,609
| +2,068% | +$5.21M | 0.04% | 609 |
|
|
2021
Q1 | $233K | Sell |
1,287
-22,523
| -95% | -$4.08M | ﹤0.01% | 1296 |
|
|
2020
Q4 | $3.37M | Sell |
23,810
-60,088
| -72% | -$8.51M | 0.03% | 563 |
|
|
2020
Q3 | $10.5M | Buy |
83,898
+61,720
| +278% | +$7.69M | 0.09% | 253 |
|
|
2020
Q2 | $1.98M | Buy |
+22,178
| New | +$1.98M | 0.02% | 624 |
|